Invicta Diagnos. (INVICTA)
STALWARTScore breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹78 |
| Market Cap | ₹77.95 Cr |
| P/E Ratio | 16.62 |
| ROCE | 46.45% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Promoter Holding | 66.7% |
| 52-Week Range | ₹58.1 — ₹104.5 |
| Sector | Healthcare Services |
Invicta Diagnos. trades with a P/E ratio of 16.62, ROCE of 46.45%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer